## Biography

Drew grew up in the Silicon Valley where his father was the early CTO of a tiny chemistry-focused startup that grew into a large, successful public company. He has entrepreneurship in his blood. He started and helped to run five companies before joining Morgenthaler Ventures. He has a solid track record of using his deep, operating experience and taking companies from two or three founders and growing them into large, multinational corporations. Drew received his BSEE and MSEE degrees from Stanford and also served on the faculty. He went on to receive an MBA from Harvard.

## Our Team

###### Dr. Grace Xiaolu Yang

COO, VP of Research & Co-founder

###### Mike Partsuf

Senior Food Scientist

###### Emily Sinovic

Public Relations Consultant

###### Todd Lorenz

Clinical Development Consultant

## Our Advisors

###### Dr. Mike P Snyder

Stanford University School of Medicine

###### Peter B Hutt

Senior Counsel at Covington & Burling LLP

###### Brad Barnes

Culinary Institute of America

###### Dr. Dariush Mozaffarian

Tufts University

###### Dr. Yung-Chi Cheng

Yale University School of Medicine

###### Dr. Danhua Xiao

Atlantic Health Metabolic Center

###### Dr. Joseph V Rodricks

Ramboll (formerly ENVIRON)

###### Alister Thomson

Bristol Myers Squibb (Former)

###### Jeff Depew

Sand Hill Angels

###### Dr. Wei Jiang

Medical Affairs at MorphoSys

## Our Board of Directors

###### Dr. Xiyan Li

Co-founder

###### Dr. Rami El Assal

Founding Partner at Boutique Venture Partners

###### Drew Lanza

Founding Partner at Berkeley Catalyst Fund

We are a clinical-stage biotechnology company based in the San Francisco Bay Area dedicated to developing novel food products for disease control.